• No results found

Erratum to: Allergen immunotherapy for allergic rhinoconjunctivitis: Protocol for a systematic review

N/A
N/A
Protected

Academic year: 2021

Share "Erratum to: Allergen immunotherapy for allergic rhinoconjunctivitis: Protocol for a systematic review"

Copied!
2
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

University of Groningen

Erratum to: Allergen immunotherapy for allergic rhinoconjunctivitis

Dhami, Sangeeta; Nurmatov, Ulugbek; Roberts, Graham; Pfaar, Oliver; Muraro, Antonella;

Ansotegui, Ignacio J.; Calderon, Moises; Cingi, Cemal; Demoly, Pascal; Durham, Stephen

Published in:

Clinical and translational allergy

DOI:

10.1186/s13601-017-0168-5

IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from

it. Please check the document version below.

Document Version

Publisher's PDF, also known as Version of record

Publication date:

2017

Link to publication in University of Groningen/UMCG research database

Citation for published version (APA):

Dhami, S., Nurmatov, U., Roberts, G., Pfaar, O., Muraro, A., Ansotegui, I. J., Calderon, M., Cingi, C.,

Demoly, P., Durham, S., van Wijk, R. G., Halken, S., Hamelmann, E., Hellings, P., Jacobsen, L., Knol, E.,

Linnemann, D. L., Lin, S., Maggina, V., ... Sheikh, A. (2017). Erratum to: Allergen immunotherapy for

allergic rhinoconjunctivitis: Protocol for a systematic review. Clinical and translational allergy, 7, [29].

https://doi.org/10.1186/s13601-017-0168-5

Copyright

Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).

Take-down policy

If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim.

Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the number of authors shown on this cover page is limited to 10 maximum.

(2)

Dhami et al. Clin Transl Allergy (2017) 7:29 DOI 10.1186/s13601-017-0168-5

ERRATUM

Erratum to: Allergen immunotherapy

for allergic rhinoconjunctivitis: protocol for a

systematic review

Sangeeta Dhami

1*

, Ulugbek Nurmatov

2

, Graham Roberts

3,4

, Oliver Pfaar

5

, Antonella Muraro

6

,

Ignacio J. Ansotegui

7

, Moises Calderon

8

, Cemal Cingi

9

, Pascal Demoly

10

, Stephen Durham

8

,

Ronald Gerth van Wijk

11

, Susanne Halken

12

, Eckard Hamelmann

13

, Peter Hellings

14

, Lars Jacobsen

15

,

Edward Knol

16

, Desiree Larenas Linnemann

17

, Sandra Lin

18

, Vivian Maggina

19

, Hanneke Oude‑Elberink

20

,

Giovanni Pajno

21

, Ruby Panwankar

22

, Elideanna Pastorello

23

, Constantinos Pitsios

24

, Giuseppina Rotiroti

25

,

Frans Timmermans

26

, Olympia Tsilochristou

27

, Eva‑Maria Varga

28

, Jamie Wilkinson

29

, Andrew Williams

30

,

Margitta Worm

31

, Luo Zhang

32

and Aziz Sheikh

33

© The Author(s) 2017. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/ publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Erratum to: Clin Transl Allergy (2016) 6:12

DOI 10.1186/s13601‑016‑0099‑6

Unfortunately this article [

1

] was published with an error in

the Funding section. The BM4SIT project is not

acknowl-edged. This section should be corrected to the below:

Funding

EAACI and the BM4SIT project (Grant Number 601763)

in the European Union’s Seventh Framework Programme

FP7.

Author details

1 Evidence‑Based Health Care Ltd, Edinburgh, UK. 2 Systematic Review at Deci‑ sion Resources Group Abacus International, Bicester, UK. 3 The David Hide Asthma and Allergy Research Centre, St Mary’s Hospital, Newport Isle of Wight, NIHR Respiratory Biomedical Research Unit, University Hospital Southampton NHS Foundation Trust, University of Southampton, Southampton, UK. 4 Faculty of Medicine, University of Southampton, Southampton, UK. 5 Department of Otorhinolaryngology, Head and Neck Surgery University Hospital, Man‑ nheim and Center for Rhinology and Allergology, Wiesbaden, Germany. 6 Food Allergy Referral Centre Veneto Region, Department of Women and Child Health, Padua General University Hospital, Padua, Italy. 7 Hospital Quiron Bizkair, Bilbao, Spain. 8 National Heart and Lung Institute, Imperial College, London, UK. 9 Department of ENT, Eskisehir Osmangazi University Medical Faculty, Eskisehir, Turkey. 10 University and Hospital of Montpellier, Inserm Paris Sorbonnes, Montpellier, France. 11 Section of Allergology, Department of Inter‑ nal Medicine, Erasmus MC, Rotterdam, The Netherlands. 12 Hans Christian Andersen Children’s Hospital, Odense University Hospital, Odense, Denmark. 13 Children’s Center Bethel, EvKB, Bieledelf and Allergy Center Buhr‑University, Bochum, Germany. 14 Laboratory of Experimental Immunology, University Hospitals Leuven, Louvain, Belgium. 15 ALC, Allergy Learning and Consulting, Copenhagen, Denmark. 16 University Medical Center, Utrecht, The Netherlands.

17 Hospital Medica Sur, Mexico City, Mexico. 18 Department of Otolaryn‑ gology‑Head and Neck Surgery, John Hopkins, Baltimore, USA. 19 Allergy and Clinical Immunology Unit, 2nd Department of Pediatrics, University of Athens, P and A Kiriakou Children’s Hospital, Athens, Greece. 20 Department of Allergology, Groningen Research Institute for Asthma and COPD (GRIAC), University Medical Center Groningen, University of Groningen, Groningen, The Netherlands. 21 Department of Pediatrics, University of Messina, Messina, Italy. 22 Department of Pediatrics, Nippon Medical School, Tokyo, Japan. 23 Univer‑ sity of Milano, Milan, Italy. 24 Department of Nutrition and Dietetics, Harokopio University, Athens, Greece. 25 The Royal National Throat, Nose and Ear Hospital, University College London, London, UK. 26 Netherlands Anafylaxis Network, Dordrecht, The Netherlands. 27 Charite University Hospital, Berlin, Germany. 28 Dept. of Paediatrics, Respiratory and Allergic Disease Division, Medical University Graz, Graz, Austria. 29 Pharmaceutical Group of the European Union, Brussels, Belgium. 30 Guy’s and St Thomas’ NHS Foundation Trust, London, UK. 31 Chartie‑Universitatsmedizin, Berlin, Germany. 32 Beijing Institute of Oto‑ larygology, Beijing, China. 33 Allergy and Respiratory Research Group, The University of Edinburgh, Edinburgh, UK.

Open Access

Clinical and

Translational Allergy

*Correspondence: sangeetadhami@hotmail.com 1 Evidence‑Based Health Care Ltd, Edinburgh, UK

Full list of author information is available at the end of the article

The online version of the original article can be found under doi:10.1186/s13601‑016‑0099‑6.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in pub‑ lished maps and institutional affiliations.

Received: 24 August 2017 Accepted: 24 August 2017

Reference

1. Dhami S, et al. Allergen immunotherapy for allergic rhinoconjunctivitis: protocol for a systematic review. Clin Transl Allergy. 2016;6:12.

Referenties

GERELATEERDE DOCUMENTEN

Printing of this thesis was financially supported by: University Medical Center Groningen (UMCG), the Graduate school of Medical Sciences Groningen (GSMS, GUIDE), Dhr.. (Kees) van

Next, we analyzed numbers of mononuclear cells (M), eosinophils (E), and neutrophils (N) in BALF and single cell suspensions of lung tissue in the GP-SCIT groups and found a

Effects of VitD3 supplemented GP-SLIT on eosinophilic inflammation and cytokine responses To assess the effect of VitD3 supplementation on airway inflammation, we compared eosinophilic

Therefore, in the current study, we analyzed the dose-dependent effects of VitD3 on GP-SCIT treatment, and we for the first time report a clear effect of high-dose VitD3 when

Our findings show how traditional business case approval practices, the degree of involvement of different stakeholders -each using different metrics-, the closeness in

Omdat hiermee ongespecificeerd blijft of de dimensie van schizofrenie of schizotypie van belang is voor de mate waarin het verband houdt met executieve functies, zal in dit

In dit onderzoek is tevens onderzocht welke verklarende rol geloofwaardigheid van de advertentie en scepticisme ten opzichte van de advertentie hebben in het effect van een

Rather, the companies that revealed to have a more flexible style to manage those factors –the ones present in our reasoning framework– accepted small requirements change as part